These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Borderline personality disorder in the primary care setting. Dubovsky AN; Kiefer MM Med Clin North Am; 2014 Sep; 98(5):1049-64. PubMed ID: 25134872 [TBL] [Abstract][Full Text] [Related]
5. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics? Abraham PF; Calabrese JR J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of pharmacotherapies for borderline personality disorder. Bellino S; Paradiso E; Bogetto F CNS Drugs; 2008; 22(8):671-92. PubMed ID: 18601305 [TBL] [Abstract][Full Text] [Related]
8. Clinical guidelines for psychotherapy for patients with borderline personality disorder. Stone MH Psychiatr Clin North Am; 2000 Mar; 23(1):193-210, ix. PubMed ID: 10729939 [TBL] [Abstract][Full Text] [Related]
10. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder. Hollander E J Clin Psychiatry; 1999; 60 Suppl 15():38-44. PubMed ID: 10418814 [TBL] [Abstract][Full Text] [Related]
11. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. American Psychiatric Association Practice Guidelines Am J Psychiatry; 2001 Oct; 158(10 Suppl):1-52. PubMed ID: 11665545 [No Abstract] [Full Text] [Related]
12. State of the art in the pharmacologic treatment of borderline personality disorder. Feurino L; Silk KR Curr Psychiatry Rep; 2011 Feb; 13(1):69-75. PubMed ID: 21140245 [TBL] [Abstract][Full Text] [Related]
13. Evaluating three treatments for borderline personality disorder: a multiwave study. Clarkin JF; Levy KN; Lenzenweger MF; Kernberg OF Am J Psychiatry; 2007 Jun; 164(6):922-8. PubMed ID: 17541052 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Borderline Personality Disorder. Levy KN; McMain S; Bateman A; Clouthier T Psychiatr Clin North Am; 2018 Dec; 41(4):711-728. PubMed ID: 30447734 [TBL] [Abstract][Full Text] [Related]
15. [Mentalization based treatment and borderline personality disorder]. De Oliveira C; Rahioui H; Smadja M; Gorsane MA; Louppe F Encephale; 2017 Aug; 43(4):340-345. PubMed ID: 27431343 [TBL] [Abstract][Full Text] [Related]
16. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. Zanarini MC; Frankenburg FR; Parachini EA J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677 [TBL] [Abstract][Full Text] [Related]
17. [Transference Focused Psychotherapy for Borderline-Adolescents in a Day Clinic Treatment Program]. Krischer M; Ponton-Rodriguez T; Gooran GR; Bender S Prax Kinderpsychol Kinderpsychiatr; 2017 Jul; 66(6):445-463. PubMed ID: 28701090 [TBL] [Abstract][Full Text] [Related]
18. Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough? Bozzatello P; Rocca P; De Rosa ML; Bellino S Expert Opin Pharmacother; 2020 Jan; 21(1):47-61. PubMed ID: 31693423 [No Abstract] [Full Text] [Related]
19. Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial. Juul S; Lunn S; Poulsen S; Sørensen P; Salimi M; Jakobsen JC; Bateman A; Simonsen S Trials; 2019 Apr; 20(1):196. PubMed ID: 30953536 [TBL] [Abstract][Full Text] [Related]